Thorne HealthTech Management

Management criteria checks 3/4

Thorne HealthTech's CEO is Paul Jacobson, appointed in Jan 2010, has a tenure of 13.75 years. total yearly compensation is $4.09M, comprised of 13% salary and 87% bonuses, including company stock and options. directly owns 1.34% of the company’s shares, worth €6.99M. The average tenure of the management team and the board of directors is 9.8 years and 8.4 years respectively.

Key information

Paul Jacobson

Chief executive officer

US$4.1m

Total compensation

CEO salary percentage13.0%
CEO tenure13.8yrs
CEO ownership1.3%
Management average tenure9.8yrs
Board average tenure8.4yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Paul Jacobson's remuneration changed compared to Thorne HealthTech's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2023n/an/a

US$20m

Mar 31 2023n/an/a

US$10m

Dec 31 2022US$4mUS$530k

US$16m

Sep 30 2022n/an/a

US$6m

Jun 30 2022n/an/a

US$3m

Mar 31 2022n/an/a

US$9m

Dec 31 2021US$13mUS$530k

US$4m

Sep 30 2021n/an/a

-US$822k

Jun 30 2021n/an/a

-US$1m

Mar 31 2021n/an/a

-US$3m

Dec 31 2020US$759kUS$530k

-US$3m

Compensation vs Market: Paul's total compensation ($USD4.09M) is above average for companies of similar size in the German market ($USD1.11M).

Compensation vs Earnings: Paul's compensation has been consistent with company performance over the past year.


CEO

Paul Jacobson (68 yo)

13.8yrs

Tenure

US$4,088,000

Compensation

Mr. Paul F. Jacobson Co-Founded Thorne HealthTech, Inc. in 2010 and has been its Chief Executive Officer and Director since 2010. He is Chairman of Thorne HealthTech, Inc. He was Interim Principal Financi...


Leadership Team

NamePositionTenureCompensationOwnership
Paul Jacobson
Co-Founder13.8yrsUS$4.09m1.34%
$ 7.0m
William McCamy
Presidentno dataUS$1.35m0.34%
$ 1.8m
Saloni Varma
CFO & Directorless than a yearUS$463.20k0.032%
$ 164.0k
Thomas McKenna
COO & Director13.8yrsUS$2.89m0.39%
$ 2.0m
Scott Hurth
Chief Technology Officer9.8yrsno datano data
Nathan Price
Chief Scientific Officer & CEO of Onegevityno datano datano data
Thomas Wilson
VP & Head of Investor Relationsno datano datano data
Kim Pearson
General Counsel28.8yrsno datano data
Michelle Crow
Chief Marketing Officer5.9yrsno datano data
Rob Monteleone
Senior VP of Professional Salesno datano datano data
Bodi Zhang
Chief Strategy Officerno datano datano data
Stephen Phipps
Chief Innovation Officer2.8yrsno datano data

9.8yrs

Average Tenure

45.5yo

Average Age

Experienced Management: F7G's management team is seasoned and experienced (9.8 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Paul Jacobson
Co-Founder13.8yrsUS$4.09m1.34%
$ 7.0m
Saloni Varma
CFO & Director2.1yrsUS$463.20k0.032%
$ 164.0k
Thomas McKenna
COO & Director13.8yrsUS$2.89m0.39%
$ 2.0m
Riccardo Braglia
Independent Director11.8yrsno data0%
$ 0
Sarah Kauss
Independent Director2.1yrsUS$469.45k0.021%
$ 108.4k
Toshitaka Inuzuka
Independent Director5yrsno data0%
$ 0

8.4yrs

Average Tenure

58.5yo

Average Age

Experienced Board: F7G's board of directors are considered experienced (8.4 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.